| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.23▲ | 7.23▲ | 7.25▲ | 6.55▲ | 5.47▲ |
| MA10 | 7.24▲ | 7.28▲ | 7.01▲ | 5.87▲ | 5.04▲ |
| MA20 | 7.22▲ | 7.02▲ | 6.81▲ | 5.36▲ | 4.08▲ |
| MA50 | 7.29▼ | 6.66▲ | 6.12▲ | 4.90▲ | 4.11▲ |
| MA100 | 7.01▲ | 6.04▲ | 5.40▲ | 4.02▲ | 3.40▲ |
| MA200 | 6.83▲ | 5.37▲ | 5.34▲ | 3.84▲ | 3.24▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.003▼ | 0.011▲ | 0.211▲ | 0.299▲ |
| RSI | 55.378▲ | 62.312▲ | 67.982▲ | 75.416▲ | 74.560▲ |
| STOCH | 46.970 | 58.169 | 76.449 | 90.582▲ | 75.526 |
| WILL %R | 0.000▲ | -25.217 | -25.217 | -9.482▲ | -7.143▲ |
| CCI | 26.002 | 40.481 | 79.974 | 153.765▲ | 156.904▲ |
|
Thursday, November 20, 2025 10:55 PM
Research and development expenses for the third quarter of 2025 increased to $9.6 million from $8.1 million for the prior year period. The increase was primarily due to a $0.9 million increase in ...
|
|
Wednesday, November 19, 2025 10:19 AM
TARA-002, a cell-based therapy by Protara Therapeutics, shows promising results in treating lymphatic malformations in pediatric patients.
|
|
Wednesday, November 19, 2025 07:22 AM
Investing.com -- Protara Therapeutics Inc (NASDAQ:TARA) stock fell 10% Wednesday despite reporting positive interim results from its Phase 2 STARBORN-1 trial evaluating TARA-002 in pediatric patients ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/11/25 | 6.47 | 7.59 | 6.44 | 7.26 | 1,674,309 |
| 20/11/25 | 6.71 | 7.06 | 6.41 | 6.44 | 1,032,347 |
| 19/11/25 | 6.38 | 6.71 | 6.005 | 6.71 | 1,483,052 |
| 18/11/25 | 5.53 | 6.85 | 5.39 | 6.75 | 1,648,478 |
| 17/11/25 | 5.49 | 5.75 | 5.39 | 5.57 | 478,879 |
| 14/11/25 | 5.01 | 5.57 | 5.00 | 5.51 | 425,172 |
| 13/11/25 | 5.21 | 5.3401 | 5.11 | 5.27 | 304,368 |
| 12/11/25 | 5.37 | 5.37 | 5.14 | 5.30 | 333,055 |
| 11/11/25 | 4.58 | 5.42 | 4.50 | 5.36 | 748,252 |
| 10/11/25 | 4.28 | 4.565 | 4.24 | 4.53 | 464,167 |
|
|
||||
|
|
||||
|
|